University College London Hospitals NHS FT
Lecanemab Homecare Service
This sits in the upper-middle of the Health & Social Care band — a substantial contract for the sector. Based on 32,734 valued Health & Social Care tenders in our corpus.
Direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service.
Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers.
The service is being offered by UCLH private Healthcare and will be for private patients only.
What the supplier must deliver
Direct supply and administration of Lecanemab (Leqembi)
Direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service.
Derived from the notice text — always confirm against the original documents.
Make the case to bid
Reveal who to approach at University College London Hospitals NHS FT, and generate a go-to-market strategy from their news, accounts and people.
- OCID
- ocds-h6vhtk-04e3d2
- Stage
- tender · Open
- Source
- Find a Tender
- Buyer ref
- 005785-2025
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Health & Social Care
Assembling the market network…
University College London Hospitals NHS FT’s tender network
Assembling the network…